From: The effect of comorbidities on survival in persons with Alzheimer’s disease: a matched cohort study
AD cohort | Non-AD cohort | ||||
---|---|---|---|---|---|
Category | IR/ 100 Person-years | Median survival time in years (min.-max.) | IR/ 100 Person-years | Median survival time in years (min.-max.) | |
Sociodemographic factors | |||||
Age Category | < 80 y | 9.22 | 5.50 (0.02–11) | 3.47 | 6.33 (0.08–11) |
≥80 y | 16.80 | 4.33 (0.02–11) | 10.22 | 4.84 (0.01–11) | |
Sex | Women | 11.81 | 5 (0.02–11) | 6.36 | 5.61 (0.01–11) |
Men | 15.15 | 4.5 (0.02–11) | 7.35 | 5.33 (0.03–11) | |
SEP | Managerial/professional | 11.33 | 4.93 (0.04–11) | 4.75 | 5.75 (0.08–11) |
Office worker | 11.75 | 4.99 (0.02–11) | 5.64 | 5.67 (0.01–11) | |
Farming/forestry | 13.85 | 4.72 (0.03–11) | 8.21 | 5.33 (0.06–11) | |
Sales/industry/cleaning | 12.99 | 4.78 (0.02–11) | 6.94 | 5.45 (0.02–11) | |
Unknown/ Did not respond | 15.24 | 4.56 (0.04–11) | 7.85 | 5.5 (0.08–11) | |
Comorbidities | |||||
Any cardiovascular disease | No | 11.24 | 5.03 (0.02–11) | 5.11 | 5.83 (0.01–11) |
Yes | 14.75 | 4.58 (0.02–11) | 8.53 | 5.16 (0.03–11) | |
Coronary artery disease | No | 11.66 | 5 (0.02–11) | 5.52 | 5.75 (0.01–11) |
Yes | 16.1 | 4.36 (0.02–11) | 10.23 | 4.89 (0.03–11) | |
Stroke | No | 12.51 | 4.85 (0.02–11) | 6.24 | 5.6 (0.01–11) |
Yes | 16.90 | 4.25 (0.02–11) | 12.96 | 4.54 (0.02–11) | |
Diabetes | No | 12.46 | 4.9 (0.02–11) | 6.32 | 5.6 (0.01–11) |
Yes | 14.82 | 4.43 (0.02–11) | 10.07 | 4.84 (0.03–11) | |
Asthma/COPD | No | 12.63 | 4.84 (0.02–11) | 6.4 | 5.58 (0.02–11) |
yes | 15.2 | 4.43 (0.05–11) | 9.43 | 5 (0.08–11) | |
History of hip fracture | No | 12.63 | 4.84 (0.02–10.91) | 6.65 | 5.58 (0.01–11) |
Yes | 18.49 | 4.08 (0.02–10.91) | 14.88 | 4.25 (0.06–11) | |
Cancer treatment within 5 years of start of follow-up | No | 12.2 | 4.91 (0.02–11) | 5.6 | 5.67 (0.01–11) |
Yes | 16.37 | 4.34 (0.02–11) | 10.93 | 4.9 (0.02–11) | |
Any mental or behavioral disorder (exc. dementia) | No | 12.28 | 4.91 (0.02–11) | 5.60 | 5.75 (0.01–11) |
Yes | 13.33 | 4.75 (0.02–11) | 7.77 | 5.30 (0.02–11) |